AMRN
Amarin Corporation PLCNASDAQHEALTHCAREDRUG MANUFACTURERS - GENERAL
Key Statistics
Market Cap
$302.58M
P/E Ratio
—
EPS
$-1.60
Beta
0.82
52W High
$20.90
52W Low
$11.03
50-Day MA
$14.61
200-Day MA
$15.45
Dividend Yield
—
Profit Margin
-15.50%
Forward P/E
500.00
PEG Ratio
0.81
About Amarin Corporation PLC
Amarin Corporation plc, a pharmaceutical company, is engaged in the development and commercialization of therapies for the treatment of cardiovascular disease in the United States. The company is headquartered in Dublin, Ireland.
Fundamentals
| Revenue (TTM) | $216.76M |
| Gross Profit (TTM) | $113.51M |
| EBITDA | $-2.26M |
| Operating Margin | -17.70% |
| Return on Equity | -7.28% |
| Return on Assets | -0.50% |
| Revenue/Share (TTM) | $10.41 |
| Book Value | $21.42 |
| Price-to-Book | 0.67 |
| Price-to-Sales (TTM) | 1.40 |
| EV/Revenue | 0.0016 |
| EV/EBITDA | -5.80 |
| Quarterly Earnings Growth (YoY) | -94.20% |
| Quarterly Revenue Growth (YoY) | 7.40% |
| Shares Outstanding | $20.97M |
| Float | $370.33M |
| % Insiders | 1.97% |
| % Institutions | 22.91% |
Historical Volatility
HV 10-Day
25.18%
HV 20-Day
27.95%
HV 30-Day
29.79%
HV 60-Day
37.76%
HV Rank
6.3%
Volatility is currently contracting
Analyst Ratings
Consensus ($12.50 target)
1
Hold1
SellMore HEALTHCARE Stocks
Data last updated: 5/25/2026